BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Digital Artificial Intelligence

Sinopia Biosciences Secures NIH Grant To Advance Data Driven Drug Discovery Platform

-Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary LEADS® drug discovery platform, annou...

January 01, 2026 | News

Insilico Medicine Signals The Arrival Of AI First Drug Development With HKD 2.27 Billion IPO

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully lis...

December 31, 2025 | News

UltraGreen Secures Dual Regulatory Approvals In Southeast Asia

UltraGreen has obtained regulatory approvals for both its Verdye in the Philippines and its IC-Flow™ Imaging System V2 in Malaysia ...

December 31, 2025 | News

Galux Partners With Boehringer Ingelheim To Advance AI Driven Precision Protein Design

-Galux, a South Korean biotech pioneering AI-driven protein therapeutics discovery, announced that it has signed a research agreement with Boehr...

December 19, 2025 | News

Talus Bioscience Enters Strategic Collaboration With PRISM BioLab To Unlock Transcription Driven Drug Targets

Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRI...

December 19, 2025 | News

UK Hospitals Adopt AI Tool MEMORI To Strengthen Early Detection Of Hospital Acquired Infections

Sanome, the health tech company behind MEMORI, an AI-powered clinical decision support tool that helps clinicians detect hospital-acquired infections (HAIs...

December 18, 2025 | News

Insilico Medicine Partners with TaiGen to Accelerate AI-Driven Anemia Therapy in Greater China

Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM48...

December 15, 2025 | News

ChemLex Establishes Global Headquarters And Self Driving Laboratory In Singapore With USD 45 Million Funding

ChemLex, a next-generation AI-for-science company,announced the establishment of its global headquarters and self-driving laboratory in Singapore, alo...

December 09, 2025 | News

Respiree Secures HSA Approval For AI Driven Acute Deterioration Detection Software

AI/ML health-tech startup Respiree has received approval from the Health Sciences Authority (HSA) for its 1Bio™AI-Acute toolbox as a Class ...

December 09, 2025 | News

Lunit Submits FDA 510k For AI Driven Five Year Breast Cancer Risk Prediction Model

Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs Lunit (KRX:328130), ...

December 09, 2025 | News

Mango Sciences Partners with ImmunoACT to Expand Access to NexCAR19 CAR-T Therapy in India

Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI company, announced a strategic partnership with ImmunoAdoptive Cell Therapy (Immu...

December 08, 2025 | News

Fujitsu Develops Multi AI Agent Collaboration Technology for Secure and Resilient Supply Chains

Fujitsu Limited announced the development of a multi-AI agent collaboration technology that enables secure collaboration and swift response to changin...

December 02, 2025 | News

Asia PGI Unveils PathGen as a Federated AI Platform for Early Outbreak Intelligence

Asia-led, "sovereign-by-design" platform built for secure, decentralised pathogen intelligence-sharing across borders aims to break data silos and provide ...

December 02, 2025 | News

Generate Plans Global Phase 3 Trials for AI Engineered GB 0895 in Severe Asthma

Generate:Biomedicines ("Generate") announced it plans to initiate two global Phase 3 clinical trials, SOLAIRIA-1 and SOLAIRIA-2, evaluating GB-0895 in appr...

December 02, 2025 | News

Stay Connected